2h8h: Difference between revisions

From Proteopedia
Jump to navigationJump to search
← Older editNewer edit →
OCA (talk | contribs)
Bots, Bureaucrats, journal, Administrators
3,331,613 edits
No edit summary
OCA (talk | contribs)
Bots, Bureaucrats, journal, Administrators
3,331,613 edits
No edit summary
Line 1: Line 1:
[[Image:2h8h.gif|left|200px]]
{{Seed}}
[[Image:2h8h.png|left|200px]]


<!--
<!--
Line 9: Line 10:
{{STRUCTURE_2h8h|  PDB=2h8h  |  SCENE=  }}  
{{STRUCTURE_2h8h|  PDB=2h8h  |  SCENE=  }}  


'''Src kinase in complex with a quinazoline inhibitor'''
===Src kinase in complex with a quinazoline inhibitor===




==Overview==
<!--  
Src family kinases (SFKs) are nonreceptor tyrosine kinases that are reported to be critical for cancer progression. We report here a novel subseries of C-5-substituted anilinoquinazolines that display high affinity and specificity for the tyrosine kinase domain of the c-Src and Abl enzymes. These compounds exhibit high selectivity for SFKs over a panel of recombinant protein kinases, excellent pharmacokinetics, and in vivo activity following oral dosing. N-(5-Chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-( tetrahydro-2H-pyran-4-yloxy)quinazolin-4-amine (AZD0530) inhibits c-Src and Abl enzymes at low nanomolar concentrations and is highly selective over a range of kinases. AZD0530 displays excellent pharmacokinetic parameters in animal preclinically and in man (t(1/2) = 40 h). AZD0530 is a potent inhibitor of tumor growth in a c-Src-transfected 3T3-fibroblast xenograft model in vivo and led to a significant increase in survival in a highly aggressive, orthotopic model of human pancreatic cancer when dosed orally once daily. AZD0530 is currently undergoing clinical evaluation in man.
The line below this paragraph, {{ABSTRACT_PUBMED_17064066}}, adds the Publication Abstract to the page
(as it appears on PubMed at http://www.pubmed.gov), where 17064066 is the PubMed ID number.
-->
{{ABSTRACT_PUBMED_17064066}}


==About this Structure==
==About this Structure==
Line 29: Line 33:
[[Category: Rowsell, S.]]
[[Category: Rowsell, S.]]
[[Category: Src kinase]]
[[Category: Src kinase]]
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May  4 05:59:30 2008''
 
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 17:15:19 2008''

Revision as of 14:15, 28 July 2008

File:2h8h.png

Template:STRUCTURE 2h8h

Src kinase in complex with a quinazoline inhibitor

Template:ABSTRACT PUBMED 17064066

About this Structure

2H8H is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.

Reference

N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5- (tetrahydro-2H-pyran-4-yloxy)quinazolin-4-amine, a novel, highly selective, orally available, dual-specific c-Src/Abl kinase inhibitor., Hennequin LF, Allen J, Breed J, Curwen J, Fennell M, Green TP, Lambert-van der Brempt C, Morgentin R, Norman RA, Olivier A, Otterbein L, Ple PA, Warin N, Costello G, J Med Chem. 2006 Nov 2;49(22):6465-88. PMID:17064066

Page seeded by OCA on Mon Jul 28 17:15:19 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "https://proteopedia.org/index.php?title=2h8h&oldid=708735"